Related Experiment Video
Updated: Jun 12, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.4K
Atrial fibrillation in the Americas
Jason G Andrade1,2, Larry R Jackson3, Juan Carlos Diaz4
1Center for Cardiovascular Innovation, Vancouver General Hospital, Vancouver, Canada.
Lancet Regional Health. Americas
|June 9, 2025
Summary
Atrial Fibrillation (AF) management varies significantly across the Americas due to regional disparities in healthcare access and resources. Addressing these health inequities is crucial to improve care and reduce the economic burden of AF.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- Atrial Fibrillation (AF) is the most prevalent sustained cardiac arrhythmia, significantly impacting patient quality of life.
- Substantial regional variations exist in AF incidence, prevalence, and consequences (e.g., disability-adjusted life years, mortality) across the Americas.
- Contemporary AF management goals are consistent, yet implementation differs widely due to access, diagnostic, and treatment variations.
Purpose of the Study:
- To highlight the regional disparities in Atrial Fibrillation management across the Americas.
- To identify key drivers of variability in AF care, including healthcare access, diagnostics, treatments, and economic factors.
- To emphasize the need for targeted healthcare policies to mitigate inequities and reduce the burden of AF.
Main Methods:
- This study synthesizes existing data on Atrial Fibrillation prevalence, incidence, and management across the Americas.
- Analysis focuses on identifying regional differences in healthcare resource allocation, technological adoption, and treatment accessibility.
- A review of health policies and economic factors influencing AF care delivery is conducted.
Main Results:
- Significant regional variations in Atrial Fibrillation incidence, prevalence, and associated mortality/morbidity are observed throughout the Americas.
- Management strategies for AF are highly variable, influenced by country-specific healthcare expenditures and access to advanced medical services and technologies.
- Disparities in access to diagnostics and treatments contribute to inconsistent AF care across different regions.
Conclusions:
- Addressing within- and between-country healthcare barriers is essential for improving Atrial Fibrillation care and reducing its economic impact.
- Failure to resolve health inequities in AF management will likely increase the strain on healthcare resources.
- Implementing tailored healthcare policies can lead to more equitable and effective Atrial Fibrillation treatment across the Americas.
Related Concept Videos
01:28Disturbances in Heart Rhythm
916
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
916
01:25Dysrhythmias VI: Management of Dysrhythmias
3
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
3